These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5799123)

  • 1. Inhibition of the hepatic metabolism of amphetamine by desipramine.
    Dingell JV; Bass AD
    Biochem Pharmacol; 1969 Jun; 18(6):1535-8. PubMed ID: 5799123
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of desmethylimipramine, iprindole and DL-erythro-alpha-(3,4-dichlorophenyl)-beta-(t-butyl amino) propanol HC1 on the metabolism of amphetamine.
    Lemberger L; Sernatinger E; Kuntzman R
    Biochem Pharmacol; 1970 Dec; 19(12):3021-8. PubMed ID: 5513039
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that (+)[3H]amphetamine binds to acceptor sites which are not MAO-A.
    Lesage A; Strolin Benedetti M; Rumigny JF
    Biochem Pharmacol; 1985 Aug; 34(16):3000-2. PubMed ID: 4026882
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of mixed-function oxidation with biosynthetic processes. 2. Inhibition of lipogenesis by aminopyrine in perfused rat liver.
    Thurman RG; Scholz R
    Eur J Biochem; 1973 Sep; 38(1):73-8. PubMed ID: 4774126
    [No Abstract]   [Full Text] [Related]  

  • 5. Further studies on the interaction between desipramine and amphetamine.
    Dolfini E; Tansella M; Valzelli L; Garattini S
    Eur J Pharmacol; 1969 Jan; 5(2):185-90. PubMed ID: 5781971
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of pyriditol on drug metabolism].
    Avakumov VM; Kovler MA
    Farmakol Toksikol; 1980; 43(4):417-21. PubMed ID: 7192219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desipramine and amphetamine metabolism.
    Consolo S; Dolfini E; Garattini S; Valzelli L
    J Pharm Pharmacol; 1967 Apr; 19(4):253-6. PubMed ID: 4382310
    [No Abstract]   [Full Text] [Related]  

  • 8. Glutathione efflux from perfused rat liver after phenobarbital treatment, during drug oxidations, and in selenium deficiency.
    Sies H; Bartoli GM; Burk RF; Waydhas C
    Eur J Biochem; 1978 Aug; 89(1):113-8. PubMed ID: 699901
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of the metabolism of H3-melatonin by phenothiazines.
    Wurtman RJ; Axelrod J; Anton-Tay F
    J Pharmacol Exp Ther; 1968 Jun; 161(2):367-72. PubMed ID: 5650143
    [No Abstract]   [Full Text] [Related]  

  • 10. Demethylation studies. VI. The inhibition of hepatic microsomal oxygenation by 2,4-dichloro(6-phenylphenoxy)ethylamine and related compounds.
    McMahon RE; Mills J; Culp HW; Gibson WR; Miller WM; Marshall FJ
    J Med Chem; 1969 Mar; 12(2):207-11. PubMed ID: 5783590
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitory mechanism of imipramine on barbiturate metabolism in rat liver.
    Kakemi K; Sezaki H; Konishi R; Kimura T
    Chem Pharm Bull (Tokyo); 1971 Jul; 19(7):1395-401. PubMed ID: 5567058
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of mixed-function oxidation with biosynthetic processes. 1. Inhibition of gluconeogenesis by aminopyrine in perfused rat liver.
    Scholz R; Hansen W; Thurman RG
    Eur J Biochem; 1973 Sep; 38(1):64-72. PubMed ID: 4149430
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.
    Brodie BB; Costa E; Groppetti A; Matsumoto C
    Br J Pharmacol; 1968 Nov; 34(3):648-58. PubMed ID: 5726793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
    Curet O; De Montigny C; Blier P
    Eur J Pharmacol; 1992 Oct; 221(1):59-70. PubMed ID: 1333978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention by antidepressant drugs of reserpine effect on pyridine nucleotide metabolism.
    Quinn GP; Greengard P; Reid MB
    Mol Pharmacol; 1966 Jul; 2(4):347-51. PubMed ID: 4290930
    [No Abstract]   [Full Text] [Related]  

  • 17. An investigation of the decrease in the metabolism of hexobarbital, aminopyrine and p-nitrobenzoic acid by liver from rats bearing a pituitary mammotropic tumor.
    Wilson JT
    J Pharmacol Exp Ther; 1968 Mar; 160(1):179-88. PubMed ID: 5639103
    [No Abstract]   [Full Text] [Related]  

  • 18. Presence of hexobarbital in primary cultures of rat hepatocytes maintains cytochrome P-450 levels and drug metabolizing enzyme activities.
    Kim HM; Ha JR; Park SK; Yang KH
    Drug Chem Toxicol; 1988; 11(1):29-41. PubMed ID: 3259924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of non-steroid antirheumatic agents on microsomal drug-metabolizing enzymes of rat liver.
    Reinicke C; Klinger W
    Biochem Pharmacol; 1971 Jul; 20(7):1405-12. PubMed ID: 5163080
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of bretylium on amine retention in rat heart.
    Krauss KR; Kopin IJ; Weise VK
    J Pharmacol Exp Ther; 1970 Apr; 172(2):282-8. PubMed ID: 4392531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.